HASLER HANS PETER has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 50000 shares of Minerva Neurosciences, Inc. ($NERV) on December 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 22, 2025 | Minerva Neurosciences, Inc. | $NERV | HASLER HANS PETER | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 7,568,981 | 9999.99% | 0.66% |
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | HASLER HANS PETER | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| Dec. 5, 2024 | Minerva Neurosciences, Inc. | $NERV | HASLER HANS PETER | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 7,578,267 | 9999.99% | 0.16% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | HASLER HANS PETER | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | HASLER HANS PETER | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |